Page 4 - OchsnerOutcomes_Cardiology

New solutions for chronic, difficult cardiovascular problems
At the John Ochsner Heart and Vascular Institute at Ochsner Medical Center, we’re not the new kids on the block. We’re established – everybody knows our name. Five years ago, we cracked U.S. News & World Report’s top-25 ranking in cardiology and heart surgery. Since being recognized, we haven’t rested on our laurels. We continue to develop our programs and make them even better. We constantly turn over rocks looking for new solutions to chronic, difficult cardiovascular problems.
In 2013, we opened our practice for same-day and next-day access to better serve our patients. In addition, we continued to grow several programs that we introduced in 2011 and 2012, including the Heart Valve Program, Adult Congenital Heart Disease Program and our Advanced Heart Failure Program offering the Total Artificial Heart.
With these programs and treatments thriving, we have also launched two new programs for chronic coronary total occlusion (CTO) and atrial appendage closure. We’re excited about the potential of these treatments to help many patients throughout the Gulf South.
We served cardiovascular patients in 2013 by providing:
• More than 100 percutaneous aortic valve replacements. Ours is the busiest transcatheter aortic valve replacement (TAVR) program in the Southeast, with the fourth-best TAVR patient length of stay in the nation.
• More than 50 left ventricular assist devices (LVADs) implanted – a record number for the Advanced Heart Failure Program.
• More than 475 complex radiofrequency ablations for arrhythmia patients – a 42 percent increase over 2012.
• Our second successful Total Artificial Heart procedure.
Christopher J. White
MD, FSCAI, FACC, FAHA, FESC
Professor and Chairman of Medicine
The Ochsner Clinical School,
University of Queensland
System Chairman of Cardiovascular Diseases Medical Director, John Ochsner Heart and Vascular Institute at Ochsner Medical Center
4
OCHSNEROUTCOMES